List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #8,951 to #9,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. CEOS → Congenital Esotropia Observational Study
  2. CEP → Cep
  3. CERCLA → Superfund
  4. CES → CES (Disambiguation page)
  5. CETP → Cholesterylester transfer protein
  6. CETP Inhibitors → Torcetrapib
  7. CEV → California encephalitis virus
  8. CE virus → California encephalitis virus
  9. CF → Cystic fibrosis
  10. CFA → Craniofacial anomalies
  11. CFC → Cardiofaciocutaneous syndrome
  12. CFR → Coronary flow reserve
  13. CFS → Chronic fatigue syndrome
  14. CFTR → Cystic fibrosis transmembrane conductance regulator
  15. CFTR gene → CFTR (gene)
  16. CF Vite → Multivitamin
  17. CGD → Chronic granulomatous disease
  18. CGG trinucleotide repeat → Trinucleotide repeat disorder
  19. CGH → Comparative genomic hybridization
  20. CGMP → Cyclic guanosine monophosphate
  21. CGPM → General Conference on Weights and Measures
  22. CGRP → Calcitonin gene-related peptide
  23. CGS → Centimetre gram second system of units
  24. CHA2-DS2-VASc score → CHA2DS2-VASc Score
  25. CHA2DS2-VASC → CHA2DS2-VASc Score
  26. CHA2DS2-VASc score → CHA2DS2-VASc Score
  27. CHADS → CHADS Score
  28. CHADS2 → CHADS Score
  29. CHADS2 Score → CHADS Score
  30. CHADS Score → CHADS2 score
  31. CHADS score → CHADS2 score
  32. CHADs Score → CHADS2 score
  33. CHAMPIONS → Controlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance
  34. CHAMPS → Controlled High-Risk Subjects Avonex Ms Prevention Study
  35. CHAPSO → CHAPS detergent
  36. CHARGE Association → CHARGE syndrome
  37. CHARISMA → Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
  38. CHARM → Candesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
  39. CHARM Added Trial → Candesartan In Heart Failure—Added Trial
  40. CHARM Alternative Trial → Candesartan In Heart Failure—Alternative Trial
  41. CHARM Overall Programme Results → Candesartan In Heart Failure—Assessment Of Reduction In Mortality And Morbidity
  42. CHARM Preserved Trial → Candesartan In Heart Failure—Preserved Trial
  43. CHA 1 → Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
  44. CHC → Hepatitis C
  45. CHD risk assessment → Coronary heart disease risk stratification
  46. CHEESE → Comparative Trial Of Hiv-Infected Patients Evaluating Efficacy And Safety Of Saquinavir-Enhanced Oral Formulation And Indinavir Given As Part Of A Triple Drug Therapy
  47. CHF → Congestive heart failure
  48. CHF-STAT → Congestive Heart Failure Survival Trial Of Antiarrhythmic Therapy
  49. CHF resident survival guide → Acute decompensated heart failure resident survival guide
  50. CHI-SQUARE → The CHI SQUARE Trial

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"